213 related articles for article (PubMed ID: 23792508)
1. Correlation between serum YKL-40 (chitinase-3-like protein 1) level and proteinuria in renal transplant recipients.
Tatar E; Gungor O; Celtik A; Sisman AR; Yaprak M; Asci G; Ozkahya M; Toz H
Ann Transplant; 2013 Mar; 18():95-100. PubMed ID: 23792508
[TBL] [Abstract][Full Text] [Related]
2. YKL-40, a novel marker of cardiovascular complications, is related to kidney function in heart transplant recipients.
Przybyłowski P; Janik L; Wasilewski G; Nowak E; Koźlik P; Małyszko J
Transplant Proc; 2014 Oct; 46(8):2860-3. PubMed ID: 25380936
[TBL] [Abstract][Full Text] [Related]
3. The serum YKL-40 level is associated with vascular injury and predicts proteinuria in nephrotic syndrome patients.
Kocyigit I; Gungor O; Dogan E; Karadavut S; Karakukcu C; Eroglu E; Orscelik O; Unal A; Dogan A; Sipahioglu MH; Tokgoz B; Oymak O
J Atheroscler Thromb; 2015; 22(3):257-64. PubMed ID: 25253160
[TBL] [Abstract][Full Text] [Related]
4. YKL-40, a marker of cardiovascular disease and endothelial dysfunction, in kidney transplant recipients.
Malyszko J; Koc-Zorawska E; Malyszko J
Transplant Proc; 2014 Oct; 46(8):2651-3. PubMed ID: 25380887
[TBL] [Abstract][Full Text] [Related]
5. Novel inflammatory marker in dialysis patients: YKL-40.
Okyay GU; Er RE; Tekbudak MY; Paşaoğlu Ö; Inal S; Öneç K; Paşaoğlu H; Altok K; Derici Ü; Erten Y
Ther Apher Dial; 2013 Apr; 17(2):193-201. PubMed ID: 23551676
[TBL] [Abstract][Full Text] [Related]
6. Elevated circulating levels of the serum acute-phase protein YKL-40 (chitinase 3-like protein 1) are a marker of obesity and insulin resistance in prepubertal children.
Kyrgios I; Galli-Tsinopoulou A; Stylianou C; Papakonstantinou E; Arvanitidou M; Haidich AB
Metabolism; 2012 Apr; 61(4):562-8. PubMed ID: 22036069
[TBL] [Abstract][Full Text] [Related]
7. YKL-40 in hemodialyzed patients with and without cardiovascular complications - the enhancement by the coexistence of the seropositivity against hepatitis C virus infection.
Pawlak K; Rozkiewicz D; Mysliwiec M; Pawlak D
Cytokine; 2013 Apr; 62(1):75-80. PubMed ID: 23490418
[TBL] [Abstract][Full Text] [Related]
8. The inflammatory biomarker YKL-40 as a new prognostic marker for all-cause mortality in patients with heart failure.
Harutyunyan M; Christiansen M; Johansen JS; Køber L; Torp-Petersen C; Kastrup J
Immunobiology; 2012 Jun; 217(6):652-6. PubMed ID: 22209156
[TBL] [Abstract][Full Text] [Related]
9. YKL-40 in type 2 diabetic patients with different levels of albuminuria.
Brix JM; Höllerl F; Koppensteiner R; Schernthaner G; Schernthaner GH
Eur J Clin Invest; 2011 Jun; 41(6):589-96. PubMed ID: 21158852
[TBL] [Abstract][Full Text] [Related]
10. Serum YKL-40/chitinase 3-like protein 1 level is an independent predictor of atherosclerosis development in patients with obstructive sleep apnea syndrome.
Bakırcı EM; Ünver E; Değirmenci H; Kıvanç T; Günay M; Hamur H; Büyüklü M; Ceyhun G; Topal E; Çoban TA
Turk Kardiyol Dern Ars; 2015 Jun; 43(4):333-9. PubMed ID: 26142786
[TBL] [Abstract][Full Text] [Related]
11. Pretransplant serum human chitinase-like glycoprotein YKL-40 concentrations independently predict bronchiolitis obliterans development in lung transplant recipients.
Jaksch P; Taghavi S; Klepetko W; Salama M
J Thorac Cardiovasc Surg; 2014 Jul; 148(1):273-81. PubMed ID: 24685381
[TBL] [Abstract][Full Text] [Related]
12. Plasma YKL-40 levels are elevated in patients with chronic heart failure.
Rathcke CN; Kistorp C; Raymond I; Hildebrandt P; Gustafsson F; Lip GY; Faber J; Vestergaard H
Scand Cardiovasc J; 2010 Apr; 44(2):92-9. PubMed ID: 19961288
[TBL] [Abstract][Full Text] [Related]
13. Increased YKL-40 levels in patients with isolated coronary artery ectasia: an observational study.
Erdoğan T; Kocaman SA; Çetin M; Durakoğlugil ME; Kırbaş A; Canga A; Yılmaz A; Doğan S; Çiçek Y
Anadolu Kardiyol Derg; 2013 Aug; 13(5):465-70. PubMed ID: 23728225
[TBL] [Abstract][Full Text] [Related]
14. The chitinase-like protein YKL-40: a possible biomarker of inflammation and airway remodeling in severe pediatric asthma.
Konradsen JR; James A; Nordlund B; Reinius LE; Söderhäll C; Melén E; Wheelock AM; Lödrup Carlsen KC; Lidegran M; Verhoek M; Boot RG; Dahlén B; Dahlén SE; Hedlin G
J Allergy Clin Immunol; 2013 Aug; 132(2):328-35.e5. PubMed ID: 23628340
[TBL] [Abstract][Full Text] [Related]
15. YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria.
Rathcke CN; Persson F; Tarnow L; Rossing P; Vestergaard H
Diabetes Care; 2009 Feb; 32(2):323-8. PubMed ID: 18957531
[TBL] [Abstract][Full Text] [Related]
16. YKL-40 and hyaluronic acid (HA) as noninvasive markers of liver fibrosis in kidney transplant patients with HCV chronic infection.
Schiavon LL; Carvalho-Filho RJ; Narciso-Schiavon JL; Medina-Pestana JO; Lanzoni VP; Ferraz ML; Silva AE
Scand J Gastroenterol; 2010 May; 45(5):615-22. PubMed ID: 20163287
[TBL] [Abstract][Full Text] [Related]
17. Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial.
Harutyunyan M; Gøtze JP; Winkel P; Johansen JS; Hansen JF; Jensen GB; Hilden J; Kjøller E; Kolmos HJ; Gluud C; Kastrup J
Immunobiology; 2013 Jul; 218(7):945-51. PubMed ID: 23294528
[TBL] [Abstract][Full Text] [Related]
18. YKL-40 levels are independently associated with albuminuria in type 2 diabetes.
Røndbjerg AK; Omerovic E; Vestergaard H
Cardiovasc Diabetol; 2011 Jun; 10():54. PubMed ID: 21696606
[TBL] [Abstract][Full Text] [Related]
19. Serum YKL-40 concentrations are elevated and correlated with disease severity in patients with obstructive sleep apnea syndrome.
Wang X; Xing GH
Scand J Clin Lab Invest; 2014 Jan; 74(1):74-8. PubMed ID: 24405178
[TBL] [Abstract][Full Text] [Related]
20. Low grade inflammation as measured by levels of YKL-40: association with an increased overall and cardiovascular mortality rate in an elderly population.
Rathcke CN; Raymond I; Kistorp C; Hildebrandt P; Faber J; Vestergaard H
Int J Cardiol; 2010 Aug; 143(1):35-42. PubMed ID: 19223085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]